94 related articles for article (PubMed ID: 8569810)
1. An evaluation of seven methods of testing in vitro susceptibility of clinical yeast isolates to fluconazole.
Schmalreck AF; Kottmann I; Reiser A; Ruffer U; Scharr E; Vanca E
Mycoses; 1995; 38(9-10):359-68. PubMed ID: 8569810
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of seven methods of in vitro susceptibility testing of clinical yeast isolates against fluconazole].
Schmalreck AF; Kottmann I; Reiser A; Ruffer U; Scharr E; Vanca E
Mycoses; 1995; 38 Suppl 1():55-63. PubMed ID: 7630372
[TBL] [Abstract][Full Text] [Related]
3. In vitro susceptibility of yeasts for fluconazole and itraconazole. Evaluation of a microdilution test.
Nenoff P; Oswald U; Haustein UF
Mycoses; 1999; 42(11-12):629-39. PubMed ID: 10680439
[TBL] [Abstract][Full Text] [Related]
4. [Susceptibility testing of fluconazole: evaluation of a multicenter study of the working group "Clinical Mycology" of the German Speaking Mycological Society].
Schmalreck AF
Mycoses; 1996; 39 Suppl 2():1-11. PubMed ID: 9198736
[TBL] [Abstract][Full Text] [Related]
5. Commercial systems for fluconazole susceptibility testing of yeasts: comparison with the broth microdilution method.
Posteraro B; Romano L; Sanguinetti M; Masucci L; Morace G; Fadda G
Diagn Microbiol Infect Dis; 2000 Sep; 38(1):29-36. PubMed ID: 11025181
[TBL] [Abstract][Full Text] [Related]
6. [Susceptibility testing of yeasts against fluconazole: comparison of the Etest method with microdilution and agar dilution].
Schmalreck AF; Kottmann I; Reiser A; Ruffer U; Vanca E
Mycoses; 1996; 39 Suppl 2():31-8. PubMed ID: 9198742
[TBL] [Abstract][Full Text] [Related]
7. Disk diffusion test and E-test with enriched Mueller-Hinton agar for determining susceptibility of Candida species to voriconazole and fluconazole.
Lee SC; Lo HJ; Fung CP; Lee N; See LC
J Microbiol Immunol Infect; 2009 Apr; 42(2):148-53. PubMed ID: 19597647
[TBL] [Abstract][Full Text] [Related]
8. Comparison of results obtained by testing with three different agar media and by the NCCLS M27-A method for in vitro testing of fluconazole against Candida spp.
Rubio MC; Gil J; De Ocáriz IR; Benito R; Rezusta A
J Clin Microbiol; 2003 Jun; 41(6):2665-8. PubMed ID: 12791899
[TBL] [Abstract][Full Text] [Related]
9. [The value of the agar dilution method as a screening test for determining the sensitivity of Candida albicans to fluconazole].
Yücesoy M; Marol S
Mikrobiyol Bul; 2002; 36(3-4):317-22. PubMed ID: 12838666
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility testing of yeasts to fluconazole by Etest and agar-diffusion disk test using the synthetic agar medium Mycoplate.
Scheven M
Mycoses; 2002 Jun; 45(5-6):156-9. PubMed ID: 12100531
[TBL] [Abstract][Full Text] [Related]
11. Rapid identification of fluconazole resistance using Chromagar Candida.
Verghese SL; Padmaja P; Sutha P; Mathew T; John ES
Indian J Pathol Microbiol; 2000 Jul; 43(3):343-6. PubMed ID: 11218683
[TBL] [Abstract][Full Text] [Related]
12. In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012.
Pfaller MA; Castanheira M; Messer SA; Jones RN
Mycoses; 2015 Apr; 58(4):209-14. PubMed ID: 25727853
[TBL] [Abstract][Full Text] [Related]
13. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
14. A global evaluation of the susceptibility of Candida species to fluconazole by disk diffusion. Global Antifungal Surveillance Group.
Meis J; Petrou M; Bille J; Ellis D; Gibbs D
Diagn Microbiol Infect Dis; 2000 Apr; 36(4):215-23. PubMed ID: 10764963
[TBL] [Abstract][Full Text] [Related]
15. X-Plate Technology: a new method for detecting fluconazole resistance in Candida species.
Chadwick SG; Schuyler JA; Vermitsky JP; Adelson ME; Mordechai E; Gygax SE
J Med Microbiol; 2013 May; 62(Pt 5):720-726. PubMed ID: 23378559
[TBL] [Abstract][Full Text] [Related]
16. Antifungal susceptibility testing of yeast isolates from blood cultures by microbroth dilution and the E test.
Simor AE; Goswell G; Louie L; Lee M; Louie M
Eur J Clin Microbiol Infect Dis; 1997 Sep; 16(9):693-7. PubMed ID: 9352266
[TBL] [Abstract][Full Text] [Related]
17. Voriconazole activity against clinical yeast isolates: a multicentre Italian study.
Morace G; Polonelli L;
Int J Antimicrob Agents; 2005 Sep; 26(3):247-53. PubMed ID: 16051469
[TBL] [Abstract][Full Text] [Related]
18. [In vitro susceptibility testing of Candida species against fluconazole using the microdilution test with Alamar Blue].
Schröder G; Bernhardt H; Schulz K
Mycoses; 1996; 39 Suppl 2():17-21. PubMed ID: 9198739
[TBL] [Abstract][Full Text] [Related]
19. CHROMagar Candida medium for direct susceptibility testing of yeast from blood cultures.
Tan GL; Peterson EM
J Clin Microbiol; 2005 Apr; 43(4):1727-31. PubMed ID: 15814992
[TBL] [Abstract][Full Text] [Related]
20. Effects of culture media on the in vitro susceptibility of selected opportunistic fungi to fluconazole and itraconazole.
Sekhon AS; Padhye AA; Garg AK; Hamir Z
Chemotherapy; 1992; 38(3):169-73. PubMed ID: 1324830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
